Evidence map›Paper›PMID 33045025›Full record

ArticlePloS one2020

ZnO and TiO2 nanoparticles alter the ability of Bacillus subtilis to fight against a stress.

Elise Eymard-Vernain, Sylvie Luche, Thierry Rabilloud, Cécile Lelong

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. ZnO Nanoparticles Enhance the Biocontrol Efficacy ofJournal of fungi (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Review
  5. Evaluation of TiOIndian journal of microbiology · 2022
    Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Elise Eymard-VernainUniversité Grenoble Alpes, CNRS, CEA, IRIG, CBM UMR CNRS5249, Grenoble, France.
Sylvie LucheUniversité Grenoble Alpes, CNRS, CEA, IRIG, CBM UMR CNRS5249, Grenoble, France.
Thierry RabilloudUniversité Grenoble Alpes, CNRS, CEA, IRIG, CBM UMR CNRS5249, Grenoble, France.ORCID 0000-0002-4372-5218
Cécile LelongUniversité Grenoble Alpes, CNRS, CEA, IRIG, CBM UMR CNRS5249, Grenoble, France.ORCID 0000-0002-0172-898X
Centre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to the physicochemical properties of nanoparticles, the use of nanomaterials increases over time in industrial and medical processes. We herein report the negative impact of nanoparticles, using solid growth conditions mimicking a biofilm, on the ability of Bacillus subtilis to fight against a stress. Bacteria have been exposed to sublethal doses of nanoparticles corresponding to conditions that bacteria may meet in their natural biotopes, the upper layer of soil or the gut microbiome. The analysis of the proteomic data obtained by shotgun mass spectrometry have shown that several metabolic pathways are affected in response to nanoparticles, n-ZnO or n-TiO2, or zinc salt: the methyglyoxal and thiol metabolisms, the oxidative stress and the stringent responses. Nanoparticles being embedded in the agar medium, these impacts are the consequence of a physiological adaptation rather than a physical cell injury. Overall, these results show that nanoparticles, by altering bacterial physiology and especially the ability to resist to a stress, may have profound influences on a "good bacteria", Bacillus subtilis, in its natural biotope and moreover, on the global equilibrium of this biotope.

Indexed as

Stress, PhysiologicalAdaptation, PhysiologicalBacillus subtilisBacterial ProteinsBiofilmsMetal NanoparticlesOxidative StressProteomeTitaniumZinc OxideBacterial ProteinsProteomeTitaniumtitanium dioxideZinc Oxide

Identifiers

PMID33045025
PMCPMC7549824
OpenAlexW3091910281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.